Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Low-molecular-weight penicillin-binding proteins (LMW PBPs) are a group of bacterial enzymes, primarily classified as Class C and Class D PBPs, that are essential for the maturation and remodeling of the peptidoglycan cell wall (Sauvage et al., 2008). Unlike high-molecular-weight PBPs that catalyze the polymerization of the glycan chain, LMW PBPs typically function as DD-carboxypeptidases or endopeptidases (Macheboeuf et al., 2006). They regulate the degree of peptidoglycan cross-linking by cleaving the terminal D-alanine from pentapeptide side chains, thereby influencing bacterial cell shape and division (Typas et al., 2011). These proteins are critical targets for beta-lactam antibiotics, which mimic the D-alanyl-D-alanine substrate and covalently bind to the active-site serine, leading to enzyme inactivation (Bush & Bradford, 2016). Although some LMW PBPs are non-essential for viability in certain laboratory conditions, they are vital for bacterial fitness, stress response, and pathogenesis during infection (Zapun et al., 2008). Inhibition of these targets contributes to the overall bactericidal effect of cell-wall-active agents by inducing structural instability and triggering autolytic pathways (Nelson & Young, 2000).
Covalent inhibition of the active-site serine residue by acting as a structural analog of the D-alanyl-D-alanine substrate, thereby preventing DD-carboxypeptidase or endopeptidase activity and disrupting peptidoglycan maturation.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Low-molecular-weight penicillin-binding protein (LMW PBP).